Secondary PRevention in Cardiovascular Disease by a Nursing Guided Program (SPRING)
SPRING
A Remote Nursing-Guided Secondary Prevention Programme in Acute Coronary Syndrome. The SPRING Randomized Controlled Trial
2 other identifiers
interventional
484
1 country
2
Brief Summary
DESIGN: Controlled clinical trial with single randomization, unmasked, open and multicentric. CENTERS: University Hospital of A Coruña and University Hospital of Ferrol CONDITION TO STUDY: Acute Coronary Syndrome (ACS). INTERVENTION:monitored outhospital not inhospital supervised. MAIN OBJECTIVE: To determine the incidence of major adverse events (total mortality, new ACS, coronary revascularization, all-cause hospitalization) during the one-year period after hospitalization for ACS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2017
CompletedFirst Posted
Study publicly available on registry
July 31, 2017
CompletedStudy Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2023
CompletedDecember 9, 2024
December 1, 2024
5.4 years
July 25, 2017
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
major adverse events
total mortality, new ACS, coronary revascularization, hospitalization for any cause
1 year
Secondary Outcomes (7)
cardiovascular mortality
1 year
cardiovascular hospitalization
one year
stroke
1 year
tobacco
1 year
physical activity
1 year
- +2 more secondary outcomes
Study Arms (2)
INTERVENTION GROUP
ACTIVE COMPARATORThe participants of this group will follow recommendations of food, physical exercise, control of consumption of drugs and consumption of alcohol and tobacco.
CONTROL GROUP
NO INTERVENTIONThe participants of this group are submitted to the standard intervention.
Interventions
Offer recommendations of healthy living habits and control of pharmacy administration
Eligibility Criteria
You may qualify if:
- Ages between 18 and 75 years.
- Patients with ability to read and understand the participation sheet in the study.
- Patients signing informed consent to participate in the study.
- Patients living in the health care area of HUAC or HUF.
You may not qualify if:
- Patients who are dependent for the Basic Activities of Daily Living (BADL) or who suffer from severe cognitive impairment (which makes reliable anamnesis impossible).
- Patients with a Left Ventricular Ejection Fraction (LVEF) less than or equal to 35%.
- Patients with a NYHA III / IV score and / or the Canadian Cardiovascular Association (CCS) scale of IV.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University Hospital of Ferrol
Ferrol, A Coruña, 15405, Spain
University Hospital of A Coruña
A Coruña, Galicia, 15006, Spain
Related Publications (1)
Fernandez-Pombo CN, Aldama-Lopez G, Lorenzo-Carpente M, Lopez-Perez M, Marzoa-Rivas R, Rodriguez-Fernandez JA, Vazquez-Rodriguez JM. A Remote Nursing-Guided Secondary Prevention Programme in Acute Coronary Syndrome. The SPRING Randomised Controlled Trial. J Adv Nurs. 2025 May 15. doi: 10.1111/jan.17046. Online ahead of print.
PMID: 40372009DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carmen Neri Fernández Pombo, PhD
University Hospital A Coruña
- PRINCIPAL INVESTIGATOR
Guillermo Aldama López, MD
University Hospital A Coruña
- PRINCIPAL INVESTIGATOR
José Manuel Vázquez Rodríguez, MD
University Hospital A Coruña
- PRINCIPAL INVESTIGATOR
Raquel Marzoa Rivas, MD
University Hospital Ferrol
- PRINCIPAL INVESTIGATOR
Manuel López Pérez, MD
University Hospital Ferrol
- PRINCIPAL INVESTIGATOR
Marta Lorenzo Carpente, Nurse
University Hospital Ferrol
- PRINCIPAL INVESTIGATOR
Jose Angel Rodriguez Fernández, MD
University Hospital A Coruña
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Nurse.
Study Record Dates
First Submitted
July 25, 2017
First Posted
July 31, 2017
Study Start
October 1, 2017
Primary Completion
February 5, 2023
Study Completion
February 5, 2023
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
The data of the participants can not be used by other researchers